Fund profile by ISIN CH1447931341
UBS SMI ETF CHF acc
Research UBS SMI ETF CHF acc by ISIN CH1447931341: TER 0.20%, domicile Switzerland, accumulating, and 1-year price performance +18.1%.
This fund 0.20% · cheapest same-index 0.20% · median 0.20%
2 of 2 ETFs tracking the SMI publish an ongoing charge. Compare every SMI ETF by cost.
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| SMIA.SW | SW | CHF | Switzerland | €682K | 157,938 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund has no German listing, so a German broker may not offer it, or may route the order to a foreign venue. As of 2026-10-13.
Largest holdings
The 10 largest holdings make up 83.76% of the fund, which holds 20 positions in total. As of 2026-10-12.
| Holding | Symbol | Weight |
|---|---|---|
| Roche Holding AG Ordinary Shares new | ROP.SW | 16.88% |
| Novartis AG Registered Shares | NOVN.SW | 15.77% |
| Nestle SA | NESN.SW | 13.48% |
| ABB Ltd | ABBN.SW | 8.51% |
| UBS Group AG Registered Shares | UBSG.SW | 8.51% |
| Compagnie Financiere Richemont SA Class A | CFR.SW | 6.63% |
| Zurich Insurance Group AG | ZURN.SW | 5.90% |
| Swiss Re AG | SREN.SW | 2.85% |
| Lonza Group Ltd | LONN.SW | 2.78% |
| Holcim Ltd | HOLN.SW | 2.45% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.